Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Fibrate dérivé")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1396

  • Page / 56

Selection :

  • and

Les hypo-lipidémiants : Des propriétés nouvelles au fil des années, les statines et les fibrates révèlent de nouvelles propriétés. Dans le domaine de l'hta, de nouvelles études s'attachent plus précisément à en cerner les conséquences = Antilipemic agentHAÏAT, Robert.Concours médical (Paris). 2001, Vol 123, Num 10, pp 24-26, issn 0010-5309, SUPConference Paper

Mode d'action moléculaire des fibrates = Molecular mechanism of action of fibratesFRUCHART, J.-C; DURIEZ, P; STAELS, B et al.Journal de la Société de biologie. 1999, Vol 193, Num 1, pp 67-75, issn 1295-0661Article

Fenofibrate-induced photosensitivityLEENUTAPHONG, V; MANUSKIATTI, W.Journal of the American Academy of Dermatology. 1996, Vol 35, Num 5, pp 775-777, issn 0190-9622, 1Article

Pharmacokinetic interactions between statins and fibratesCORSINI, Alberto; BELLOSTA, Stefano; DAVIDSON, Michael H et al.The American journal of cardiology. 2005, Vol 96, Num 9A, pp 44K-49K, issn 0002-9149, SUPConference Paper

Differential associations of statin and fibrate treatment with carotid arterial remodelingCHIRONI, Gilles; SIMON, Alain; GARIEPY, Jérome et al.American journal of hypertension. 2005, Vol 18, Num 11, pp 1476-1481, issn 0895-7061, 6 p.Article

Effects of ethyl-CPIB (clofibrate) on tissue lipoprotein lipase and plasma post-heparin lipolytic activity in ratsODONKOR, J. M; PERENNA ROGERS, M.Biochemical pharmacology. 1984, Vol 33, Num 8, pp 1337-1341, issn 0006-2952Article

Rhabdomyolyse induite par le fénofibrate en monothérapie = Rhabdomyolysis induced by fenofibrate monotherapyARCHAMBEAUD-MOUVEROUX, F; LOPEZ, S; COMBES, C et al.La Revue de médecine interne (Paris). 2006, Vol 27, Num 7, pp 573-574, issn 0248-8663, 2 p.Article

Les anticholestérolémiants, nouvelles approches thérapeutiques = Anti-cholesterol agents, new therapeutic approachesFRUCHART, J.-C; DURIEZ, P.Annales pharmaceutiques françaises. 2004, Vol 62, Num 1, pp 3-18, issn 0003-4509, 16 p.Article

A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in ratsISHIHARA, Kenji; KATSUTANI, Naruo; AOKI, Toyohiko et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 3, pp 251-260, issn 1742-7835, 10 p.Article

Study of the liquid chromatography retention of some fibrate-type antihyperlipidemic drugs on C18 and CN columns : Application for quantitation in pharmaceutical formulationsMISZTAL, Genowefa; KOMSTA, Łukasz.Journal of AOAC International. 2005, Vol 88, Num 2, pp 479-489, issn 1060-3271, 11 p.Article

Studies on the reactivity of clofibryl-S-acyl-CoA thioester with glutathione in vitroGRILLO, Mark P; BENET, Leslie Z.Drug metabolism and disposition. 2002, Vol 30, Num 1, pp 55-62, issn 0090-9556Article

Gynecomastia associated with fenofibrateGARDETTE, Virginie; VEZZOSI, Delphine; MAIZA, Jean-Christophe et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 3, pp 508-511, issn 1060-0280, 4 p.Article

Safety considerations with fibrate therapy. CommentaryDAVIDSON, Michael H; ARMANI, Annemarie; MCKENNEY, James M et al.The American journal of cardiology. 2007, Vol 99, Num 6A, issn 0002-9149, 3C-21C, SUPArticle

Simultaneously measuring concentrations of a model drug and a model excipient in solution using ultrasonic spectrometryCHEN, Raymond R; ZELESKY, Todd; ILASI, Nicholas et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 2, pp 239-247, issn 0731-7085, 9 p.Article

Self-micellization of gemfibrozil 1-O-β acyl glucuronide in aqueous solutionSHACKLEFORD, David M; PRANKERD, Richard J; SCANLON, Martin J et al.Pharmaceutical research. 2003, Vol 20, Num 3, pp 465-470, issn 0724-8741, 6 p.Article

Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8 : Implications for drug-drug interactionsOGILVIE, Brian W; DONGLU ZHANG; WENYING LI et al.Drug metabolism and disposition. 2006, Vol 34, Num 1, pp 191-197, issn 0090-9556, 7 p.Article

Pas de fénofibrate en prévention cardiovasculaire = Fenofibrate for cardiovascular preventionLa Revue Prescrire. 2006, Vol 26, Num 271, pp 296-296, issn 0247-7750, 1 p.Article

Effect of gemfibrozil on the pharmacokinetics of pioglitazoneDENG, Li-Jing; FENG WANG; LI, Huan-De et al.European journal of clinical pharmacology. 2005, Vol 61, Num 11, pp 831-836, issn 0031-6970, 6 p.Article

Potent hypolipidemic activity of mimetic amides of fibrates based on the 2-methoxy-4-(2-propenyl)phenoxyacetic scaffoldHERNANDEZ, Dolores; BERNAL, Pablo; CRUZ, Adriana et al.Drug development research. 2004, Vol 61, Num 1, pp 19-36, issn 0272-4391, 18 p.Article

Fenofibrate-induced elevation in serum creatinineRITTER, Janet L; NABULSI, Shereen.Pharmacotherapy. 2001, Vol 21, Num 9, pp 1145-1149, issn 0277-0008Article

Fenofibrate-induced cirrhosisAHMED, Furqaan; PETROVIC, Lydia; ROSEN, Ellen et al.Digestive diseases and sciences. 2005, Vol 50, Num 2, pp 312-313, issn 0163-2116, 2 p.Article

Gemfibrozil metabolite inhibits in vitro low-density lipoprotein (LDL) oxidation and diminishes cytotoxicity induced by oxidized LDLKAWAMURA, M; MIYAZAKI, S; TERAMOTO, T et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 4, pp 479-485, issn 0026-0495Article

The sialic acid content of fibrinogen decreases during pregnancy and increases in response to fibrate therapyMAGHZAL, Ghassan J; BRENNAN, Stephen O; GEORGE, Peter M et al.Thrombosis research. 2005, Vol 115, Num 4, pp 293-299, issn 0049-3848, 7 p.Article

Fibrates in the metabolic syndrome and in diabetesSTEINER, George.Endocrinology and metabolism clinics of North America. 2004, Vol 33, Num 3, pp vi-vii, issn 0889-8529, 13 p.Article

Mécanismes d'action des statines et des fibrates = Mechanism of action of statins and fibratesDURIEZ, Patrick.Thérapie (Paris). 2003, Vol 58, Num 1, pp 5-14, issn 0040-5957, 10 p.Article

  • Page / 56